Erratum: Withdrawal: Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. (Journal of Biological Chemistry (2018) 291 (3254–3267) Doi:10.1074/jbc.M113.492314);Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes

Journal of Biological Chemistry

Volumn 288, Issue 52, 2013, Pages 36994-37009

  Iqbal, Jawed ^a   McRae, Steven ^a   Banaudha, Krishna ^b   Mai, Thi ^a   Waris, Gulam ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; VIRUSES;

CELL MIGRATION; EPITHELIAL TO MESENCHYMAL TRANSITIONS; HEPATITIS C VIRUS; HEPATOCYTES; OSTEOPONTIN;

CALCIUM COMPOUNDS;

CALPAIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CALCIUM SIGNALING; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SITE DIRECTED MUTAGENESIS;

HEPATITIS C VIRUS;

EID: 84891444844     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.W118.006978     Document Type: Erratum

References (66)

1. Di Bisceglie, A. M. (1997) Hepatitis C and hepatocellular carcinoma. Hepatology 26, S34-S38
2. Blight, K. J., Kolykhalov, A. A., and Rice, C. M. (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974
3. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G., Mizokami, M., Bartenschlager, R., and Liang, T. J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796
4. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., and Chisari, F. V. (2005) Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102, 9294-9299
5. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics. CA Cancer J. Clin. 55, 74-108
6. Llovet, J. M., and Bruix, J. (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48, 1312-1327
7. Kern, M. A., Breuhahn, K., and Schirmacher, P. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Adv. Cancer Res. 86, 67-112
8. Huang, Y. H., Wu, J. C., Chen, C. H., Chang, T. T., Lee, P. C., and Chau, G. Y. (2005) Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int. 25, 236-241
9. Moriya, K., Nakagawa, K., Santa, T., Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Miyazawa, T., Ishibashi, K., Horie, T., Imai, K., Todoroki, T., Kimura, S., and Koike, K. (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 61, 4365-4370
10. Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., Ichikawa, T., Ishikawa, H., Nakao, K., and Eguchi, K. (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97, 3036-3043
11. Gong, G., Waris, G., Tanveer, R., and Siddiqui, A. (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc. Natl. Acad. Sci. U.S.A. 98, 9599-9604
12. Presser, L. D., Haskett, A., and Waris, G. (2011) Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication. Virology 412, 284-296
13. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890
14. Mee, C. J., Farquhar, M. J., Harris, H. J., Hu, K., Ramma, W., Ahmed, A., Maurel, P., Bicknell, R., Balfe, P., and McKeating, J. A. (2010) Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138, 1134-1142
15. Rangaswami, H., Bulbule, A., and Kundu, G. C. (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 16, 79-87
16. Wai, P. Y., and Kuo, P. C. (2008) Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 27, 103-118
17. Patouraux, S., Bonnafous, S., Voican, C. S., Anty, R., Saint-Paul, M. C., Rosenthal-Allieri, M. A., Agostini, H., Njike, M., Barri-Ova, N., Naveau, S., Le Marchand-Brustel, Y., Veillon, P., Calès, P., Perlemuter, G., Tran, A., and Gual, P. (2012) The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 7, e35612
18. Whalen, K. A., Weber, G. F., Benjamin, T. L., and Schaffhausen, B. S. (2008) Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J. Virol. 82, 4946-4954
19. Zhang, X., Ye, L. H., and Zhang, X. D. (2010) A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase. Acta Pharmacol. Sin. 31, 593-600
20. Brown, A., Islam, T., Adams, R., Nerle, S., Kamara, M., Eger, C., Marder, K., Cohen, B., Schifitto, G., McArthur, J. C., Sacktor, N., and Pardo, C. A. (2011) Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J. Neurovirol. 17, 382-392
21. Stein, G. S., Stein, J. L., Van Wijnen, A. J., Lian, J. B., Montecino, M., Croce, C. M., Choi, J. Y., Ali, S. A., Pande, S., Hassan, M. Q., Zaidi, S. K., and Young, D. W. (2010) Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer. Adv. Enzyme Regul. 50, 160-167
22. Xiang, Z., Qiao, L., Zhou, Y., Babiuk, L. A., and Liu, Q. (2010) Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1. Biochem. Biophys. Res. Commun. 402, 549-553
23. Burdette, D., Olivarez, M., and Waris, G. (2010) Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J. Gen. Virol. 91, 681-690
24. Qadri, I., Iwahashi, M., Capasso, J. M., Hopken, M. W., Flores, S., Schaack, J., and Simon, F. R. (2004) Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem. J. 378, 919-928
25. Waris, G., Turkson, J., Hassanein, T., and Siddiqui, A. (2005) Hepatitis C virus constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J. Virol. 79, 1569-1580
26. Presser, L. D., McRae, S., and Waris, G. (2013) Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion. PLoS One 8, e56367
27. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., and Perret, C. (1998) Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 95, 8847-8851
28. Moon, R. T., Kohn, A. D., De Ferrari, G. V., and Kaykas, A. (2004) WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701
29. Liu, Y. N., Kang, B. B., and Chen, J. H. (2004) Transcriptional regulation of human osteopontin promoter by C/EBPa and AML-1 in metastatic cancer cells. Oncogene 23, 278-288
30. Banaudha, K., Orenstein, J. M., Korolnek, T., St Laurent, G. C., 3rd, Wakita, T., and Kumar, A. (2010) Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis. Hepatology 51, 1922-1932
31. Korenaga, M., Wang, T., Li, Y., Showalter, L. A., Chan, T., Sun, J., and Weinman, S. A. (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280, 37481-37488
32. Ming-Ju, H., Yih-Shou, H., Tzy-Yen, C., and Hui-Ling, C. (2011) Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. J. Cell. Biochem. 112, 233-243
33. Bureau, C., Bernad, J., Chaouche, N., Orfila, C., Béraud, M., Gonindard, C., Alric, L., Vinel, J. P., and Pipy, B. (2001) Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J. Biol. Chem. 276, 23077-23083
34. Hijiya, N., Setoguchi, M., Matsuura, K., Higuchi, Y., Akizuki, S., and Yamamoto, S. (1994) Cloning and characterization of the human osteopontin gene and its promoter. Biochem. J. 303, 255-262
35. Hu, T., Luan, R., Zhang, H., Lau, W. B., Wang, Q., Zhang, Y., Wang, H.-C., and Tao, L. (2009) Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 36, 626-630
36. Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., and Detmar, M. (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149, 293-305
37. Standal, T., Borset, M., and Sundan, A. (2004) Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp. Oncol. 26, 179-184
38. Waris, G., Livolsi, A., Imbert, V., Peyron, J. F., and Siddiqui, A. (2003) Hepatitis C virus NS5A and subgenomic replicon activate NF-κB via tyrosine phosphorylation of IκBα and its degradation by calpain protease. J. Biol. Chem. 278, 40778-40787
39. Thorgeirsson, S. S., and Grisham, J. W. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31, 339-346
40. Farazi, P. A., and DePinho, R. A. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 6, 674-687
41. Naas, T., Ghorbani, M., Alvarez-Maya, I., Lapner, M., Kothary, R., De Repentigny, Y., Gomes, S., Babiuk, L., Giulivi, A., Soare, C., Azizi, A., and Diaz-Mitoma, F. (2005) Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis Cvirus core and envelope proteins 1 and 2. J. Gen. Virol. 86, 2185-2196
42. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K. (1998) The core protein of hepatitis-C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4, 1065-1067
43. Cao, D. X., Li, Z. J., Jiang, X. O., Lum, Y. L., Khin, E., Lee, N. P., Wu, G. H., and Luk, J. M. (2012) Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J. Gastroenterol. 18, 3923-3930
44. Colli, A., Fraquelli, M., and Conte, D. (2006) α-Fetoprotein and hepatocellular carcinoma. Am. J. Gastroenterol. 101, 1939
45. Piccoli, C., Scrima, R., Quarato, G., D'Aprile, A., Ripoli, M., Lecce, L., Boffoli, D., Moradpour, D., and Capitanio, N. (2007) Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46, 58-65
46. 2+ uniporter activity. FASEB J. 21, 2474-2485
47. Prevarskaya, N., Skryma, R., and Shuba, Y. (2011) Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 11, 609-618
48. Nishikawa, M., and Inoue, M. (2008) Oxidative stress and tissue injury. Masui. 57, 321-326
49. 3 engagement and PI3K/pAkt/NFκB signaling. Hepatology 55, 594-608
50. Wu, W. S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705
51. Zhang, J., Yamada, O., Matsushita, Y., Chagan-Yasutan, H., and Hattori, T. (2010) Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-enhanced Tax protein. Leuk. Res. 34, 763-768
52. Molinari, M., and Carafoli, E. (1997) Calpain: a cytosolic proteinase active at the membranes. J. Membr. Biol. 156, 1-8
53. Witkowski, J. M., Zmuda-Trzebiatowska, E., Swiercz, J. M., Cichorek, M., Ciepluch, H., Lewandowski, K., Bryl, E., and Hellmann, A. (2002) Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100, 1802-1809
54. Mamoune, A., Luo, J. H., Lauffenburger, D. A., and Wells, A. (2003) Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res. 63, 4632-4640
55. Mochida, S., Yoshimoto, T., Mimura, S., Inao, M., Matsui, A., Ohno, A., Koh, H., Saitoh, E., Nagoshi, S., and Fujiwara, K. (2004) Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem. Biophys. Res. Commun. 317, 114-120
56. Bose, S. K., Meyer, K., Di Bisceglie, A. M., Ray, R. B., and Ray, R. (2012) Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J. Virol. 86, 13621-13628
57. Cha, M. Y., Kim, C. M., Park, Y. M., and Ryu, W. S. (2004) Hepatitis B virus X protein is essential for the activation of Wnt/κ-catenin signaling in hepatoma cells. Hepatology 39, 1683-1693
58. Morrison, J. A., Klingelhutz, A. J., Raab-Traub, N. (2003) Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J. Virol. 77, 12276-12284
59. Park, C. Y., Choi, S. H., Kang, S. M., Kang, J. I., Ahn, B. Y., Kim, H., Jung, G., Choi, K. Y., and Hwang, S. B. (2009) Nonstructural 5A protein activates β-catenin signaling cascade: implication of hepatitis C virus-induced liver pathogenesis. J. Hepatol. 51, 853-864
60. Liu, J., Ding, X., Tang, J., Cao, Y., Hu, P., Zhou, F., Shan, X., Cai, X., Chen, Q., Ling, N., Zhang, B., Bi, Y., Chen, K., Ren, H., Huang, A., He, T. C., and Tang, N. (2011) Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS One 6, e27496
61. Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., and Lu, Z. (2007) Phosphorylation of β-catenin by Akt promotes β-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229
62. Street, A., Macdonald, A., McCormick, C., and Harris, M. (2005) Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular-catenin and stimulation of β-catenin-responsive transcription. J. Virol. 79, 5006-5016
63. Hirohashi, S. (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153, 333-339
64. Wilson, G. K., Brimacombe, C. L., Rowe, I. A., Reynolds, G. M., Fletcher, N. F., Stamataki, Z., Bhogal, R. H., Simões, M. L., Ashcroft, M., Afford, S. C., Mitry, R. R., Dhawan, A., Mee, C. J., Hübscher, S. G., Balfe, P., and McKeating, J. A. (2012) A dual role for hypoxia inducible factor-1α in the hepatitis C virus life cycle and hepatoma migration. J. Hepatol. 56, 803-809
65. Li, T., Li, D., Cheng, L., Wu, H., Gao, Z., Liu, Z., Jiang, W., Gao, Y. H., Tian, F., Zhao, L., and Wang, S. (2010) Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Ann. Surg. Oncol. 17, 1937-1944
66. Moradpour, D., Englert, C., Wakita, T., and Wands, J. R. (1996) Characterization of cell lines allowing tightly regulated expression of hepatitis-C virus core protein. Virology 222, 51-63